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Longitudinal cancer spread is very important for staging of resectability in bile duct can-
cer. We verified the difference in methylene blue staining properties between cancerous
and noncancerous epithelia that are usually observed by cholangioscopy. We obtained
45 biopsy specimens from the common bile duct of 20 patients with bile duct disease
using percutaneous transhepatic cholangioscopy (PTCS) after staining with 0.05%
methylene blue. We compared the microscopic staining properties with the gross endo-
scopic observations and evaluated the characteristics of methylene blue staining on
frozen sections of each type of cholangial epithelium. Microscopic staining properties
were significantly associated with endoscopic observations (p 0.00001). While 18 of 20
(90%) specimens of normal epithelia stained with methylene blue, 11 of 16 (69%) speci-
mens of metaplastic epithelia were stained, with no staining obtained in cancerous
epithelia. The cancerous epithelia stained significantly less often than either the normal
p 0.000005) or the metaplastic p 0.001) epithelia. Evaluation of methylene blue
staining during PTCS revealed that this stain was absorbed by the cholangial epithelia,
not superficially stuck to it. The difference in methylene blue staining properties between
the cancerous and normal epithelia could be helpful to clarify the boundary of superfi-
cial lateral spread of bile duct cancer.
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INTRODUCTION
Longitudinal cancer spread is very important for stag-
ing and assessment of resectability in bile duct cancer.
Percutaneous transhepatic cholangioscopy (PTCS) is
highly useful in the diagnosis of malignant biliary
stenosis, especially of the mucosal spread of carci-
noma in the bile duct. Since 1987, we have usually
performed PTCS to accurately evaluate all patients
with malignant-appearing bile duct strictures. A papil-
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logranular surface of the bile duct reportedly indicates
the presence of such mucosal spread 1-4]. However,
this finding is reportedly related not to carcinoma, but
rather to the papillary proliferation of the superficial
epithelia [4]. Thus, the precise diagnosis of mucosal
spread of biliary carcinoma may be difficult by only
PTCS observation.
Methylene blue staining is reportedly useful for
observing the mucosal surface and diagnosing lesions
in the stomach and colon. We recently applied this
staining method to the diagnosis of bile duct disorders
[2,4]. We previously found that mucosa covered with
non-neoplastic epithelium stained with methylene
blue, whereas the mucosa covered with neoplastic
epithelia did not stain underPTCS observation with an
irrigating saline solution. To study these phenomena,
we examined the staining properties of the bile duct
epithelium by evaluating frozen sections of biopsy
materials taken from the bile duct during PTCS, which
was described by Tada et al. [9].
MATERIALS AND METHODS
We studied 45 biopsy specimens taken from the com-
mon bile duct of 20 patients with biliary disease
(Table I). There were 12 men and 8 women aged 31 to
88 years (mean 69.8 years). Before PTCS was con-
ducted, percutaneous transhepatic cholangiodrainage
and dilation of the sinus tract were performed up to 16
or 18 Fr. About 7 days later, we performed PTCS
through the sinus tract without a sheath using a CHF-
P20 or CHF-T20 cholangioscope (Olympus). At first,
regular observation with saline was performed. Then,
TABLE Clinical diagnoses of 17 patients from whom 39 biopsy
specimens were obtained
No. of patients No. of specimens
Pancreatic cancer 7 17
Common bile duct cancer 6 12
Gall bladder cancer 2 5
Common bile duct stone 2 4
Gastric cancer 2 4
Congenital biliary dilatation 3
Total 20 45
20 ml ofmethylene blue solution (0.05%) was injected
into the bile duct via the working channel of the
cholangioscope. Three minutes later, this solution was
aspirated, and the bile duct lumen was washed with
saline solution using the scope. When no remaining
methylene blue solution was observed in the bile duct
lumen, we began our observation of the bile duct
mucosa irrigated with saline.
We first determined whether the microscopic stain-
ing properties of the tissue were associated with the
endoscopic characteristics recognized during PTCS.
We then evaluated the staining characteristics of the
superficial epithelia of the bile duct.
Some biopsy specimens were obtained with for-
ceps during PTCS. After these biopsy specimens
were frozen in OCT compound, two frozen sections
were obtained from each specimen. One section was
used as the nonstained section, while the other was
stained with hematoxylin and eosin (HE). Non-HE
stained sections were available for the examination
of the staining properties of methylene blue with the
results classified as stained and unstained (Figs.
and 2). We regarded stained epithelia of any degree
being the stained group. HE-stained sections were
available for the diagnosis of superficial epithelia:
normal, metaplastic, and cancerous epithelia.
Fisher’s exact probability test was used for statistical
analysis of the data. p < 0.05 was considered to be
statistically significant.
RESULTS
Relationship between Endoscopic Methylene Blue
Staining Characteristics and its Absorption by
Cholangial Epithelia
Seven biopsy specimens that were taken from a region
seen on PTCS to be stained, were not stained micro-
scopically, including 2 normal epithelia, 2 metaplastic
epithelia, and 3 cancerous epithelia (Table II). All but 7
specimens taken from the regions observed to be
stained on PTCS showed staining microscopically. No
stained materials were seen microscopically in the
specimens taken from the regions observed to be
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FIGURE Micrographs of the cholangial normal epithelia stained with methylene blue (example of stained epithelia). A. Section stained
with HE showing normal epithelia. B. Same section without HE showing epithelia to be well stained with methylene blue.
A B
FIGURE 2 Micrographs of the cholangial metaplastic epithelia unstained with methylene blue (example of unstained epithelia). A. Section
stained with HE showing normal epithelia. B. Same section without HE showing epithelia to be unstained with methylene blue.32 I. MAETANI et al.
TABLE II Comparison of the absorption characteristics of
methylene blue for cholangial epithelia in the biopsy specimen vs.
gross endoscopic observations in that region
MB absorption
Endoscopy No. of specimens present absent
Stained 36 29 7
Unstained 9 0 9
*P 0.00001 by Fisher’s exact probability test
MB: methylene blue
Staining Properties ofNormal, Metaplastic,
and Cancerous Epithelia Evaluated by
Microscopy and Endoscopy
Of specimens with normal epithelia, 90% (18 of 20)
stained with methylene blue, with only 2 of 20 speci-
mens (10%) being unstained. Of specimens with meta-
plastic epithelia, 69% (11 of 16) stained. No staining
of the cancerous epithelia occurred, irrespective of
grade of staining (Table III).
Microscopic staining properties were associated
with those observed endoscopically (p 0.00001).
Findings showed that most of the normal and meta-
plastic epithelia stained with methylene blue (Fig. 3),
whereas the cancerous epithelia was unstained (Fig.
4). The cancerous epithelia stained significantly less
often than either the normal (p 0.000005) or the
metaplastic (p 0.001) epithelia.
DISCUSSION
Cancer of the bile duct is often complicated by lateral
carcinomatous spread, both intramural and superficial
[5,6]. PTCS is the most useful method of diagnosing
TABLE III Absorption of methylene blue by each type of
cholangial epithelium
MB absorption
Type of epithelium No. of specimens present absent
Proper 20 18 2*
Metaplastic 16 11 5**
Cancerous 9 0 9
*p 0.000005, **p 0.001 by Fisher’s exact probability test
MB: methylene blue
such lateral superficial spread precisely-[1-4]. In some
patients with cancer extension seen on PTCS before
attempted resection, hepatectomy with pancreatoduo-
denectomy was required. This suggests that PTCS
offers a great advantage over analysis of resection
margins with frozen sections at the time of surgery.
And, it is more useful to detect the multiple foci of bile
duct carcinoma that followed in a few patients.
Some authors report that a papillogranular surface
of the bile duct is associated with positivity for carci-
noma [1,3,4], especially with noninvasive mucosal
carcinoma [4], while vascular dilation of cholangio-
scopic findings is related to invasive carcinoma [4].
However, Sato et al. [4] reported that a papillogranu-
lar surface was more closely related to the papillary
proliferation of the superficial epithelia [4]. Those
authors concluded that a papillogranular surface is
not always carcinomatous [4]. Therefore, it is diffi-
cult to differentiate a carcinomatous from a noncarci-
nomatous papillogranular surface. In the stomach,
carcinomatous epithelium was not stained with
methylene blue; therefore, the methylene blue stain-
ing method could be helpful to clarify the boundary
between cancerous epithelium and noncancerous
epithelium [7]. Miyakawa et al. [8] reported PTCS
with the methylene blue dyeing method using CO2
gas instead of saline solution. They reported that
cholangial mucosa was endoscopically dyed in 47%
of lesions out of adenocarcinoma of the bile duct.
However, they did not histologically ascertain that the
superficial mucosa of the dyed lesion was adenocarci-
noma or not. And they reported that all erosions and
inflammatory granulomas were dyed intensely. Their
results that the mucosa was changed to blue even in
the area lacking epithelium, such as erosion and gran-
uloma, can be explained as follows. They observed
that methylene blue was not only absorbed in the
epithelium, but also it was attached to the mucosal
surface or mucus on the epithelium. This may result
from using a higher concentration of methylene blue
(0.5 to 1.0%) and CO2 gas instead of saline solution.
We previously observed that areas of the superfi-
cial mucosa positive for cancer were not stained in
some cases of malignant biliary stenosis as a result of
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FIGURE 3 Endoscopic views of the common bile duct after complete removal of a common bile duct stone. A. Normal cholangial mucosa
with a smooth surface. B. Cholangial mucosa stained with methylene blue.
FIGURE 4 Endoscopic views and micrographs of bile duct cancer with mucosal superficial spread. Left top: Papillogranular surface extend-
ing from the bile duct stenosis to the hepatic hilum. Right top: The methylene blue staining method identifies the boundary between the area
covered with cancerous epithelia and that covered with normal epithelia. Left bottom: Section stained with HE showing papillogranular pro-
liferation with cancerous epithelia. Right bottom: Same section as left bottom: showing lack of methylene blue staining of cancerous epithe-34 I. MAETANI et al.
sought to confirm whether methylene blue just
adhered to the superficial mucosa or was absorbed.
We therefore studied the specific methylene blue
staining properties of the bile duct mucosa, including
the normal, metaplastic, and cancerous epithelia.
Tada et al. [9] studied the methylene blue staining
properties of the gastric metaplastic epithelia using
frozen sections of the biopsy specimens and demon-
strated that methylene blue was absorbed. We used
the same method of examination in this study.
Because Tada et al. [9] reported that the methylene
blue absorbed in the superficial epithelia disappeared
with time, we placed biopsy specimens in OCT com-
pound, made frozen sections, and immediately
observed the specimens microscopically after taking
them from the bile duct. Methylene blue pigment was
lodged in the epithelial cells of the bile duct, as
observed by Tada et al. in studying the intestinal
metaplastic epithelia of the stomach. However,
whether the methylene blue pigment was present in
the cytoplasm .or the nucleus was not determined.
Tada et al. reported that intestinal metaplasia with a
brush border on the apical portion stained with meth-
ylene blue. The mechanism of methylene blue
absorption was not described. We have shown that
most of the normal epithelia stained well, while the
cancerous epithelia did not stain with methylene blue.
The number of stained specimens of metaplastic
epithelia was less than that of normal epithelia, but
the difference was not statistically significant. These
results demonstrate that the staining properties of the
normal epithelia differ, especially from those of can-
cerous epithelia. Microscopic findings for methylene
blue staining in the seven biopsy specimens differed
from their endoscopic findings. Our results suggest
that methylene blue may be attached to the mucus on
the epithelium, or the mucus may have disturbed the
contact of methylene blue with the superficial epithe-
lia. Removal of the superficial mucus will therefore
help to accurately evaluate the methylene blue stain-
ing properties of cholangial epithelia. This problem
remains to be resolved.
In conclusion, our results indicate that the staining
ofthe cholangial epithelia by methylene blue observed
during PTCS represents the absorption of methylene
blue. There is a difference in methylene blue staining
properties between cancerous and normal epithelia.
The methylene blue staining method could be helpful
in clarifying the boundary of superficial lateral spread
of bile duct cancer.
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